Jodi Regts
Public Communications Contact at XENON PHARMACEUTICALS INC.
Profile
Jodi Regts is currently the Head of Corporate Affairs at Xenon Pharmaceuticals, Inc. and the Head of Investor Relations & Communications at Perimeter Medical Imaging AI, Inc. Previously, Jodi held positions as the Director of Investor Relations & Communications at Forbes Medi-Tech, Inc. from 2008 to 2009, the Director of Investor Relations at Arbutus Biopharma Corp.
from 2011 to 2014, the Director of Investor Relations at lululemon athletica, Inc. from 2014 to 2015, the Communications Director at The Centre for Drug Research & Development from 2009 to 2011, and the Senior Manager of Investor Relations at Angiotech Pharmaceuticals, Inc. from 2005 to 2008.
Jodi also served as the Vice President of Corporate Relations at Pug Pharm Productions, Inc. Jodi's education includes an undergraduate degree and an MBA from the University of Victoria.
Jodi Regts active positions
| Companies | Position | Start |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Public Communications Contact | 2015-11-30 |
| PERIMETER MEDICAL IMAGING AI, INC. | Investor Relations Contact | - |
Former positions of Jodi Regts
| Companies | Position | End |
|---|---|---|
| LULULEMON ATHLETICA INC. | Investor Relations Contact | 2014-12-31 |
| ARBUTUS BIOPHARMA CORPORATION | Investor Relations Contact | 2013-12-31 |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Public Communications Contact | 2010-12-31 |
Forbes Medi-Tech, Inc.
 Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | Public Communications Contact | 2008-12-31 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Public Communications Contact | 2007-12-31 |
Training of Jodi Regts
| University of Victoria | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| LULULEMON ATHLETICA INC. | Retail Trade |
| PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada | Health Technology |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Commercial Services |
Pug Pharm Productions, Inc.
 Pug Pharm Productions, Inc. Internet Software/ServicesTechnology Services Pug Pharm Productions, Inc. operates an online entertainment platform. The firm's products include Picnic, G+Play, i-Cardz and Con X. It serves the gamification industry. The company was founded in 2008 by Steve Bocska and is headquartered in Vancouver, Canada. | Technology Services |
- Stock Market
- Insiders
- Jodi Regts
